Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its price target decreased by JPMorgan Chase & Co. from $260.00 to $250.00 in a research report sent to investors on Monday, The Fly reports. Other equities analysts have also issued reports about the company. Wedbush restated an outperform rating on shares of Karuna Therapeutics in a research […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its target price reduced by JPMorgan Chase & Co. from $260.00 to $250.00 in a report published on Monday, The Fly reports. Other equities analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating on shares of Karuna Therapeutics in a research report on […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating)‘s stock had its “maintains” rating reaffirmed by equities research analysts at 58.com in a report released on Monday, Benzinga reports. A number of other analysts have also recently commented on the company. Wedbush reiterated an “outperform” rating on shares of Karuna Therapeutics in a research report on Tuesday, March […]
Sectoral Asset Management Inc. boosted its stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 12.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,810 shares of the company’s stock after buying an additional 2,500 shares during the […]
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) have been given a consensus rating of “Moderate Buy” by the sixteen analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 […]